U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
· 8/14/2026, 7:27:12 AM· 2 min read
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Read original story →Related stories
hyderabad
‘Agadha’ movie review: Kamakshi Bhaskarla shines, but style outruns substance
hyderabad
Kamakshi Bhaskarla on her journey from medicine to Telugu cinema and ‘Agadha’
hyderabad
Dakkhan ko Chira: Hyderabad exhibition explores the textile heritage of the western Deccan
hyderabad